Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Human Vaccines and Immunotherapeutics is Scopus-indexed (Q1, CiteScore 7.4), WoS SCIE, DOAJ. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 2164-5515Verify ISSN ↗2164-554XVerify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology | 74 / 328 | 77th | Q1 |
| Immunology and Allergy | 61 / 234 | 74th | Q2 |
| Immunology | 67 / 243 | 72nd | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2012–present, best quartile Q1, CiteScore 7.4.
Human Vaccines and Immunotherapeutics is Q1 in Pharmacology (rank 74 of 328), Q2 in Immunology and Allergy (rank 61 of 234) and Q2 in Immunology (rank 67 of 243), by CiteScore 2025.
Human Vaccines and Immunotherapeutics is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7.4, which places it in quartile Q1 at the 77th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.094, quartile Q1, with an H-index of 113.
The publisher lists an article processing charge of about US$3,175 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Human Vaccines and Immunotherapeutics is published by Taylor and Francis Ltd. Its print ISSN is 2164-5515 and its online ISSN is 2164-554X.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Human Vaccines and Immunotherapeutics has an h-index of 131 and a 2-year mean of 4.29 citations per paper (OpenAlex). Its Scopus CiteScore is 7.4, quartile Q1. On 2-year citations it ranks #63 of 319 Scopus journals in Pharmacology.
Human Vaccines and Immunotherapeutics published 548 papers in 2025; its busiest recent year was 2021 with 641. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2026), authors are most often from China (39.5%), United States (13.2%) and United Kingdom (6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 10 retracted papers are recorded (1.4 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.